These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21361292)

  • 1. Activation of the G-protein-coupled receptor 119: a conformation-based hypothesis for understanding agonist response.
    McClure KF; Darout E; Guimarães CR; DeNinno MP; Mascitti V; Munchhof MJ; Robinson RP; Kohrt J; Harris AR; Moore DE; Li B; Samp L; Lefker BA; Futatsugi K; Kung D; Bonin PD; Cornelius P; Wang R; Salter E; Hornby S; Kalgutkar AS; Chen Y
    J Med Chem; 2011 Mar; 54(6):1948-52. PubMed ID: 21361292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 5-nitropyrimidine analogs with azabicyclic substituents as GPR119 agonists.
    Yang Z; Fang Y; Pham TA; Lee J; Park H
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1519-21. PubMed ID: 23374864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel histamine H4 receptor antagonists.
    Lane CA; Hay D; Mowbray CE; Paradowski M; Selby MD; Swain NA; Williams DH
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1156-9. PubMed ID: 22189138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines as orally available G protein-coupled receptor 119 agonists.
    Katamreddy SR; Carpenter AJ; Ammala CE; Boros EE; Brashear RL; Briscoe CP; Bullard SR; Caldwell RD; Conlee CR; Croom DK; Hart SM; Heyer DO; Johnson PR; Kashatus JA; Minick DJ; Peckham GE; Ross SA; Roller SG; Samano VA; Sauls HR; Tadepalli SM; Thompson JB; Xu Y; Way JM
    J Med Chem; 2012 Dec; 55(24):10972-94. PubMed ID: 23214471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationship of fused-pyrimidine derivatives as a series of novel GPR119 agonists.
    Negoro K; Yonetoku Y; Moritomo A; Hayakawa M; Iikubo K; Yoshida S; Takeuchi M; Ohta M
    Bioorg Med Chem; 2012 Nov; 20(21):6442-51. PubMed ID: 23010456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR studies of bicyclic amine series GPR119 agonists.
    Sakairi M; Kogami M; Torii M; Kataoka H; Fujieda H; Makino M; Kataoka D; Okamoto R; Miyazawa T; Okabe M; Inoue M; Takahashi N; Harada S; Watanabe N
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5123-8. PubMed ID: 22765901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of thienopyrimidine derivatives as GPR119 agonists.
    Jeon MK; Lee KM; Kim IH; Jang YK; Kang SK; Lee JM; Jung KY; Kumar JA; Rhee SD; Jung WH; Song JS; Bae MA; Kim KR; Ahn JH
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4281-5. PubMed ID: 25082125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists.
    Gillespie P; Goodnow RA; Saha G; Bose G; Moulik K; Zwingelstein C; Myers M; Conde-Knape K; Pietranico-Cole S; So SS
    Bioorg Med Chem Lett; 2014 Feb; 24(3):949-53. PubMed ID: 24412066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of diazatricyclodecane agonists of the G-protein-coupled receptor 119.
    Darout E; Robinson RP; McClure KF; Corbett M; Li B; Shavnya A; Andrews MP; Jones CS; Li Q; Minich ML; Mascitti V; Guimarães CR; Munchhof MJ; Bahnck KB; Cai C; Price DA; Liras S; Bonin PD; Cornelius P; Wang R; Bagdasarian V; Sobota CP; Hornby S; Masterson VM; Joseph RM; Kalgutkar AS; Chen Y
    J Med Chem; 2013 Jan; 56(1):301-19. PubMed ID: 23234271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
    Semple G; Fioravanti B; Pereira G; Calderon I; Uy J; Choi K; Xiong Y; Ren A; Morgan M; Dave V; Thomsen W; Unett DJ; Xing C; Bossie S; Carroll C; Chu ZL; Grottick AJ; Hauser EK; Leonard J; Jones RM
    J Med Chem; 2008 Sep; 51(17):5172-5. PubMed ID: 18698756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationship of 4-amino-2-phenylpyrimidine derivatives as a series of novel GPR119 agonists.
    Negoro K; Yonetoku Y; Maruyama T; Yoshida S; Takeuchi M; Ohta M
    Bioorg Med Chem; 2012 Apr; 20(7):2369-75. PubMed ID: 22365911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational restriction in a series of GPR119 agonists: differences in pharmacology between mouse and human.
    Scott JS; Brocklehurst KJ; Brown HS; Clarke DS; Coe H; Groombridge SD; Laber D; MacFaul PA; McKerrecher D; Schofield P
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3175-9. PubMed ID: 23628336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.
    Serby MD; Zhao H; Szczepankiewicz BG; Kosogof C; Xin Z; Liu B; Liu M; Nelson LT; Kaszubska W; Falls HD; Schaefer V; Bush EN; Shapiro R; Droz BA; Knourek-Segel VE; Fey TA; Brune ME; Beno DW; Turner TM; Collins CA; Jacobson PB; Sham HL; Liu G
    J Med Chem; 2006 Apr; 49(8):2568-78. PubMed ID: 16610800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triamino pyrimidines and pyridines as histamine H(4) receptor modulators.
    Meduna SP; Savall BM; Cai H; Edwards JP; Thurmond RL; McGovern PM
    Bioorg Med Chem Lett; 2011 May; 21(10):3113-6. PubMed ID: 21458260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and biological evaluation of novel 4-amino-2-phenylpyrimidine derivatives as potent and orally active GPR119 agonists.
    Negoro K; Yonetoku Y; Misawa-Mukai H; Hamaguchi W; Maruyama T; Yoshida S; Takeuchi M; Ohta M
    Bioorg Med Chem; 2012 Sep; 20(17):5235-46. PubMed ID: 22836190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives.
    Geiger C; Zelenka C; Lehmkuhl K; Schepmann D; Englberger W; Wünsch B
    J Med Chem; 2010 May; 53(10):4212-22. PubMed ID: 20441176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel pyrimido[5,4-d]pyrimidine derivatives as GPR119 agonist for treatment of type 2 diabetes.
    Fang Y; Xu J; Li Z; Yang Z; Xiong L; Jin Y; Wang Q; Xie S; Zhu W; Chang S
    Bioorg Med Chem; 2018 Aug; 26(14):4080-4087. PubMed ID: 30100020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyridylmethylamines as highly selective 5-HT(1A) superagonists.
    Bollinger S; Hübner H; Heinemann FW; Meyer K; Gmeiner P
    J Med Chem; 2010 Oct; 53(19):7167-79. PubMed ID: 20860381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonists.
    Lowe JA; DeNinno SL; Coe JW; Zhang L; Mente S; Hurst RS; Mather RJ; Ward KM; Shrikhande A; Rollema H; Johnson DE; Horner W; Gorczyca R; Tingley FD; Kozak R; Majchrzak MJ; Tritto T; Sadlier J; Shaffer CL; Ellerbrock B; Osgood SM; MacDougall MC; McDowell LL
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4749-52. PubMed ID: 20663668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of novel fused pyrimidine derivatives as GPR119 agonists.
    Fang Y; Xiong L; Hu J; Zhang S; Xie S; Tu L; Wan Y; Jin Y; Li X; Hu S; Yang Z
    Bioorg Chem; 2019 May; 86():103-111. PubMed ID: 30685641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.